Are elevated blood eosinophils a marker of allergic/atopic immune activation and mucosal inflammation?

Eosinophils are bone-marrow-derived granulocytes that play a central role in the Type 2 (Th2) immune response. Their elevation in the peripheral blood is a primary biomarker for systemic allergic activation and is frequently linked to inflammatory processes at mucosal surfaces.

Clinical and mechanistic associations

Elevated blood eosinophils (absolute eosinophil count, or AEC) are strongly indicative of atopic immune activation. This process is driven by the release of Th2 cytokines, specifically Interleukin-5 (IL-5), which stimulates the maturation and release of eosinophils from the bone marrow via the Jak2-STAT1 signaling pathway.

• Airways and Skin: In conditions like asthma and atopic dermatitis, peripheral eosinophilia correlates with disease severity. For instance, in atopic dermatitis, elevated AEC (e.g., mean 537 cells/mm³) mirrors systemic Th2 dominance. In asthma, blood AEC is a recognized surrogate for eosinophilic airway inflammation and is often associated with elevated serum periostin levels.
• Gastrointestinal Tract: While blood eosinophilia is often present in eosinophilic gastrointestinal disorders (EGIDs), the correlation is less precise. In eosinophilic esophagitis (EoE), peripheral counts often fail to accurately reflect the severity of mucosal infiltration. Clinical guidelines emphasize that a diagnosis of EoE requires tissue biopsy (≥15 eosinophils per high-power field), as blood AEC lacks the sensitivity to replace histology.

Physiological recruitment

The migration of eosinophils from the blood to the mucosa is mediated by specific chemoattractants, notably eotaxins, which bind to the CCR3 receptor on the eosinophil surface. This mechanism facilitates the targeted recruitment of cells to the respiratory, cutaneous, and gastrointestinal barriers during an allergic challenge.

Bottom line

Elevated blood eosinophils are highly characteristic of allergic and atopic activation, serving as a reliable marker for systemic Type 2 inflammation. While they are frequently associated with mucosal inflammation in the airways and skin, peripheral counts are not sufficiently specific to confirm mucosal involvement in the gut without direct histological evidence.